New study investigates muscle effects of Weight-Loss drug tirzepatide

NCT ID NCT07373834

Recruiting now Knowledge-focused Sponsor: University Medical Centre Ljubljana Source: ClinicalTrials.gov ↗

First seen Jan 29, 2026 · Last updated May 24, 2026 · Updated 17 times

Summary

This study looks at how tirzepatide, a weight-loss medication, affects muscle strength, structure, and metabolism in women with obesity. Thirty premenopausal women will receive either tirzepatide or a placebo for 24 weeks. Researchers will measure body composition, muscle function, and take muscle samples to understand changes at the cellular level. The goal is to learn more about how this drug impacts muscle health during weight loss.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY (DISORDER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana
RECRUITING

Ljubljana, 1000, Slovenia

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

OBESITY (DISORDER)